Bernard “Bernie” W. Chang, M.D., director of plastic and reconstructive surgery at Mercy Medical Center, and head of The Breast Reconstruction and Restoration Center at Mercy, and
Craig A. Vander Kolk, M.D. director of cosmetic medicine and surgery and associate director, plastic and reconstructive surgery, have been named among America’s Best Plastic Surgeons 2021 by Newsweek.
Board certified in plastic surgery and general surgery, Chang pioneered and advanced surgical treatment options like DIEP flap surgery for breast reconstruction. Chang, who also serves as assistant director of The Hoffberger Breast Center at Mercy, works closely with Mercy’s breast surgical team to provide seamless care for women who choose immediate breast reconstruction after breast surgery.
Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic
Targeted Intraoperative Radiotherapy or TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients
Image courtesy of Zeiss
December 21, 2020 According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.
However, physicians at Mercy Medical Center are countering this trend with a procedure called Targeted Intraoperative Radiotherapy, or TARGIT-IORT using the Intrabeam System from ZEISS. Mercy was the first hospital in Maryland to acquire the INTRABEAM Radiotherapy System in 2012, and remains the only hospital in the
Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic
Share Article
Targeted Intraoperative Radiotherapy or TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients. Mercy Medical Center in Baltimore, MD, is offering TARGIT-IORT using the Intrabeam® System. Mercy was the first hospital in Maryland to acquire the INTRABEAM® Radiotherapy System in 2012. BALTIMORE (PRWEB) December 16, 2020 SINGLE-DOSE RADIATION THERAPY CAN COUNTERACT SERIOUS BREAST CANCER TREATMENT COMPLIANCE ISSUES DURING PANDEMIC
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 6-week radiotherapy, significantly reducing COVID-19 risk to patients
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronaviru
Single-dose radiation therapy may lessen, eliminate unsafe additional outside trips during the pandemic
According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.
However, physicians at Mercy Medical Center are countering this trend with a procedure called Targeted Intraoperative Radiotherapy, or TARGIT-IORT using the Intrabeam
® System from ZEISS. Mercy was the first hospital in Maryland to acquire the INTRABEAM
® Radiotherapy System in 2012, and remains the only hospital in the state to offer patients the INTRABEAM system.